Good afternoon, everyone. This is Daniel Fairclough from the ArcelorMittal Investor Relations team. Thank you for joining this call to discuss ArcelorMittal's performance and progress in 2025. Present ...
Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results